Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine function in amyotrophic lateral sclerosis. A review.

S Melmed, G D Braunstein

    Neurologic Clinics
    |February 1, 1987
    PubMed
    Summary

    Patients with Amyotrophic Lateral Sclerosis (ALS) exhibit endocrine and metabolic issues, including pancreatic, carbohydrate, calcium, and hormonal dysfunctions. These disturbances may be linked to ALS etiology or be secondary effects of the disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society.

    Pituitary·2025
    Same author

    Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs).

    Pituitary·2025
    Same author

    Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE).

    Pituitary·2024
    Same author

    Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers.

    Pituitary·2023
    Same author

    Expression of leukemia inhibitory factor in craniopharyngioma.

    Endocrine pathology·2016
    Same author

    Sagit©: A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

    Area of Science:

    • Endocrinology
    • Metabolic Medicine
    • Neurodegenerative Diseases

    Background:

    • Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder.
    • Endocrine and metabolic abnormalities are increasingly recognized in ALS patients.
    • The relationship between these disturbances and ALS pathogenesis remains unclear.

    Purpose of the Study:

    • To review and interpret endocrine and metabolic disturbances observed in patients diagnosed with ALS.
    • To explore the potential role of these metabolic dysfunctions in the etiology or as epiphenomena of ALS.

    Main Methods:

    • Comprehensive literature review of studies investigating endocrine and metabolic functions in ALS.
    • Analysis of data concerning pancreatic function, carbohydrate tolerance, calcium metabolism, and pituitary/thyroid/gonadal axes.
    • Interpretation of findings within the context of ALS pathophysiology.

    Main Results:

    • Patients with ALS display a range of metabolic alterations.
    • Specific dysfunctions include impaired pancreatic exocrine and endocrine function, altered glucose metabolism, and abnormalities in calcium homeostasis.
    • Hormonal imbalances affecting the thyroid, pituitary, and gonadal systems are also noted.

    Conclusions:

    • The reviewed data highlight significant endocrine and metabolic disturbances in ALS.
    • Distinguishing between disease-related epiphenomena and potential etiological factors requires further investigation.
    • These metabolic findings may offer insights into ALS pathogenesis and potential therapeutic targets.

    Related Experiment Videos